Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an

Huihong Zhai1, Yongquan Shi, Haifeng Jin

  • 1State Key Laboratory of Cancer Biology, Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

Insights

Calcyclin-binding protein (CacyBP)/Siah-1 interacting protein (SIP) is highly expressed in various cancers. This study maps CacyBP/SIP expression in normal and tumor tissues, revealing its ubiquitous presence in tumors and potential role in tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Proteomics

Background:

  • Calcyclin-binding protein (CacyBP)/Siah-1 interacting protein (SIP) is involved in ubiquitin-mediated proteolysis and has been linked to beta-catenin degradation.
  • Previous research indicated CacyBP/SIP modulates multidrug resistance in gastric cancer and is upregulated in these tissues.

Purpose of the Study:

  • To comprehensively analyze the protein expression profile of CacyBP/SIP across a wide spectrum of human normal tissues and carcinomas.
  • To establish a baseline understanding of CacyBP/SIP expression patterns for future functional studies in tumorigenesis.

Main Methods:

  • Immunohistochemistry staining using a newly developed anti-CacyBP/SIP monoclonal antibody.
  • Analysis of CacyBP/SIP protein localization (cytoplasm/nucleus) and expression levels in diverse human tissues and cancer types.

Main Results:

  • CacyBP/SIP exhibited positive staining in brain, heart, lymph node, and esophagus, with weak staining in the rectum and kidney; it was undetectable in most other normal tissues.
  • In contrast, CacyBP/SIP was ubiquitously detected in all analyzed tumor tissues.
  • Notably high expression levels of CacyBP/SIP were observed in nasopharyngeal carcinoma, osteogenic sarcoma, and pancreatic cancer.

Conclusions:

  • This study presents the first extensive analysis of CacyBP/SIP expression in human normal and tumor tissues.
  • The findings highlight CacyBP/SIP as a potential pan-cancer marker with significantly elevated expression in numerous malignancies.
  • This expression data provides a crucial reference for future research into the functional roles of CacyBP/SIP in cancer development.